Green Tea and Breast Cancer
Breast cancer is the most prevalent form of cancer in women the world over. Green tea made from tea plant leaves (Camellia sinensis) has been found to contain flavonoids, which are antioxidants in the polyphenol group.
The results of surveys comparing medical histories between green tea drinkers and non-drinkers show that green tea can inhibit breast cancer cell growth. The most effective flavonoid in cancer prevention is thought to be epigallocatechin-gallate (EGCG).
A Review of Published Studies
A lot of research has been conducted since 1998 about the effects of green tea on breast cancer. This is because many studies, whether epidemiological, molecular or clinical have generated results proving that green tea has some anti-inflammatory and anti-cancerous properties. AA Ogunleye and his colleagues conducted a systematic search of studies of breast cancer risk and recurrence that were published between 1998 and 2009.1
The researchers used 5 databases of published studies and found 5617 cases of breast cancer. Of those cases, they pinpointed 7 studies of breast cancer incidence and 2 studies of breast cancer recurrence that included green tea consumption as a variable. There was a great deal of variation in the results. They concluded there is probably a beneficial effect of green tea on breast cancer even though the studies were so variable. There is a clear need for more studies under controlled conditions to make any definitive conclusions.
A literature review of the effects green tea, green tea extract or its purified polyphenol (-)-epigallocatechin-3-gallate (EGCG), an antioxidant, on health benefits was conducted by Y. Clement, from the University of the West Indies.2 Data was gleaned from 2 electronic databases: PubMed (1966 to 2009) and the Cochrane Library (Issue 4, 2008). Although observations were made from observational studies Clement concluded there are trends toward green tea assisting in the prevention of breast cancer incidence.
Green tea has proved to have anti-tumor ability. In a laboratory experiment, cells infected with human breast cancer cells grew cancerous tumors. Following cell treatment with green tea polyphenols or EGCG tumor growth was inhibited and tumor cells were killed.3
A current experimental study looked at the effect of green tea on the efficacy of a common chemotherapy drug, paclitaxel, with taxol as the active ingredient.4 Taxol is extracted from the bark of the Pacific yew tree (Taxus brevifolia). Over time, cancer cells can develop resistance paclitaxel. The identification of “chemosensitizers”, substances that make cancer cells more susceptible to chemotherapy treatment, is vital for cancer treatment as the second decade of the 21st century begins.
One such chemosensitizer has proven to be EGCG extracted from green tea. Researchers compared cancer cell death when treated with the chemotherapy drug paclitaxel alone, with EGCG alone or paclitaxel and EGCG in combination. The combination of the two substances showed the most significant effect on tumor destruction than either one alone (a synergistic effect).
Common stumbling blocks when using natural chemicals, such as polyphenolic compounds, in the human body are bioavailability and instability in the living system. The chemicals may be stable and bioavailable until the compound is introduced to the body. There are many reactions the natural chemicals are subject to and the environment within the body may not be hospitable for them.
So along with the development of chemosensitizers for use in disease treatment, “prodrugs” are sometimes required to maintain the viability of the treatment under physiologic conditions. Researchers have developed a prodrug of EGCG called Pro-EGCG (1) to increase the stability, bioavailability and anticancer activities of EGCG.5
EGCG is unstable in the body and is poorly bioavailable. The researchers, when trying to create a prodrug for EGCG, added chemical groups to the areas on the molecule that are available to react with other molecules. The researchers named the new molecule Pro-EGCG (1). Now the EGCG can be protected by preventing other molecules from attaching to it and forming completely different molecules that would likely not have anti-cancerous effects. EGCG and Pro-EGCG (1) given in combination enhances tumor cell death and growth suppression and has potential use in preventing and treating cancer.
1Green tea consumption and breast cancer risk or recurrence: a meta-analysis.
Ogunleye, AA, Xue F, Michels KB. Breast Cancer Res Treat. 2010 Jan;119(2):477-84. Epub 2009 May 13.
2Can green tea do that? A literature review of the clinical evidence. Clement Y. Prev Med. 2009. 49(2-3):83-7. Epub 2009 May 22.
3Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo. Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK. Cancer. Lett. 2007. 245(1-2):232-41. Epub 2006 Mar 6.
4(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Ting Luo, Jiao Wang, Yancun Yin , Hui Hua, Jing Jing, Xiangming Sun, Minjing Li, You Zhang and Yangfu Jiang. Breast Cancer Research. 2010. 12(1):R8.
5 A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent. Landis-Piwowar KR, Huo C, Chen D, Milacic V, Shi G, Chan TH, Dou QP. Cancer Res. 2007. 67(9):4303-10.
